Insider · CIK 0001581950

Cantley Lewis Clayton Jr.

CIK 0001581950 Name as filed on the most recent filing

Filed as Cantley Lewis Clayton Jr. (31)

142 transaction lines · from 31 filings · filed 2015-03-30 to 2017-12-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

142 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-12-28 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 339,272, disposed Open Form 4 filing 0001209191-15-087315
2015-11-17 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 418,815, disposed Open Form 4 filing 0001209191-16-110214
2015-11-17 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 418,815, disposed Open Form 4 filing 0001209191-15-080920
2015-11-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 162,190, disposed Open Form 4 filing 0001209191-16-110214
2015-11-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 144,056, disposed Open Form 4 filing 0001209191-15-080920
2015-10-23 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 296,481, disposed Open Form 4 filing 0001209191-15-076838
2015-10-22 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 297,015, disposed Open Form 4 filing 0001209191-15-076838
2015-09-25 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 398,252, disposed Open Form 4 filing 0001209191-15-072318
2015-09-24 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 409,630, disposed Open Form 4 filing 0001209191-15-072318
2015-08-18 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 464,288, disposed Open Form 4 filing 0001209191-15-066874
2015-08-17 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 457,034, disposed Open Form 4 filing 0001209191-15-066874
2015-07-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 554,026, disposed Open Form 4 filing 0001209191-15-061536
2015-07-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 554,899, disposed Open Form 4 filing 0001209191-15-061536
2015-06-25 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 512,662, disposed Open Form 4 filing 0001209191-15-056467
2015-06-24 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 507,495, disposed Open Form 4 filing 0001209191-15-056467
2015-05-20 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 565,743, disposed Open Form 4 filing 0001209191-15-045457
2015-05-19 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 566,107, disposed Open Form 4 filing 0001209191-15-045457
2015-04-24 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 516,592, disposed Open Form 4 filing 0001209191-15-036416
2015-04-23 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 503,759, disposed Open Form 4 filing 0001209191-15-036416
2015-03-27 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 467,442, disposed Open Form 4 filing 0001209191-15-030223
2015-03-26 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 440,683, disposed Open Form 4 filing 0001209191-15-030223

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 142
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Cantley Lewis Clayton Jr., insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001581950

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.